Batch Notification View

Batch Notification Number BN-OL-2022-09-20-4837
FDA Registered Product/Generic Name Co-Amoxiclav
Brand Name Co-Amoxisaph-125
Dosage Strength 156.25 mg per 5 mL
Dosage Form Powder for Suspension
Registration Number DRP-4131
Batch Number NAX-12
Lot Number N/A
Product Expiration Date 1 November 2024
Issuance Date 28 September 2022